Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Clearway Energy LLC reported a significant increase in net income for the nine months ended September 30, 2026, reaching $95 million compared to a net loss of $56 million in the prior year period. Total operating revenues grew to $1.36 billion, driven by portfolio expansions and acquisitions, while total assets increased to $17.3 billion as of September 30, 2026.
Ibotta Chief Revenue Officer Christopher J. Riedy Sells $736K of Stock
Christopher J. Riedy, Chief Revenue Officer, sold 12,259 shares of Ibotta, Inc. at $60.00 a share, worth $736K in total on Nov 5, 2026. Shares held after the trade: 351,128 (-3.4%).
FreightCar America reported Q3 2026 revenues of $76.5 million and railcar deliveries of 662 units, reflecting a challenging period compared to the prior year. Despite lower production, the company saw 65% growth in aftermarket revenue and a 28% increase in backlog value to $284.5 million. Management reaffirmed its full-year 2026 guidance for revenue and Adjusted EBITDA.
Term
Q3 2026
“While our third quarter results reflect a challenging period for the business, they were consistent with the preliminary figures we reported in October. We continued to make progress on our commercial priorities, with order intake through the first nine months exceeding our total for all of 2025 and backlog value up 28% year over year.”
Nick Randall, President and Chief Executive Officer
“Our balance sheet remains solid, with no borrowings under our revolving credit facility. Our cost structure has improved, and our aftermarket business is contributing a growing share of our results.”
Bank7 Corp. reported net income of $30.6 million for the nine months ended September 30, 2026, a slight decrease from $32.3 million in the prior year period. Total assets grew to $2.01 billion, driven by a modest increase in the loan portfolio and cash balances, while shareholders' equity rose to $273.7 million.
WEBTOON Entertainment Inc. filed its 10-Q for the period ending September 30, 2026, reporting 135,783,781 shares of common stock outstanding as of October 30, 2026. The filing highlights the company's focus on its global web-comic and web-novel ecosystem, including key platforms like LINE MANGA, NAVER SERIES, and Wattpad, while identifying as an accelerated filer.
Ethan Allen Interiors Inc. reported net sales of $129.6 million for the first quarter of fiscal 2027, a decrease from $147.0 million in the prior year period. Net income declined significantly to $1.7 million compared to $10.5 million, primarily driven by lower sales volume and a substantial $92.2 million cash dividend payment during the quarter.
Stryker Corporation has increased its board size from 11 to 12 and elected James E. Davis as a new independent director, effective January 1, 2027. Mr. Davis currently serves as the Chairman, CEO, and President of Quest Diagnostics and brings extensive experience from GE Healthcare and McKinsey & Company. He will receive compensation consistent with the company's existing non-employee director pay structure.
Structure Therapeutics is a large accelerated filer reporting a limited operating history with significant operating losses and four product candidates currently in clinical development: aleniglipron, ACCG-2671, ACCG-3535, and LTSE-2578. As of October 31, 2026, the company had 214,771,065 ordinary shares outstanding and expects to require substantial additional capital to fund future operations.
Rocket Lab reported total revenues of $267.8 million for the quarter ended September 30, 2026, a significant increase from $155.1 million in the prior year. Despite the revenue growth, the company recorded a net loss of $79.7 million for the quarter, driven by increased research and development costs and a $27.3 million loss on the extinguishment of debt.
Ferguson Enterprises Inc. reported net sales of $9,026 million for the three months ended September 30, 2026, an increase from $8,245 million in the prior year period. Operating profit for the nine-month period rose to $2,390 million compared to $2,193 million in 2025, while the company completed the acquisition of FloWorks on August 31, 2026.
For the nine months ended September 30, 2026, Myomo, Inc. reported revenue of $34.1 million, a 15.5% increase compared to the same period in 2025. While the company reduced its operating loss to $7.1 million from $11.6 million year-over-year, it still recorded a net loss of $11.3 million due to significant non-cash charges related to the change in fair value of derivative liabilities.
Attovia Therapeutics is an emerging growth company focused on developing product candidates ATTO-1310, ATTO-2306, and ATTO-1091 for inflammatory and pruritic diseases. As of October 31, 2026, the company had 45,712,536 shares of common stock outstanding and continues to incur significant operating losses with no product revenue generated to date.
HF Foods Group reported third quarter 2026 net revenue of $319.6 million, a 4.1% increase year-over-year, marking its seventh consecutive quarter of growth. The company reported a GAAP net loss of $4.2 million, impacted by higher fuel costs and professional fees related to its acquisition of Searay Foods and debt refinancing. Management highlighted the successful integration of Searay Foods, representing the company's first expansion outside the United States.
Term
Q3 2026
“Our third quarter results reflect solid top line growth, marking our seventh consecutive quarter of year-over-year net revenue growth, even as industry-wide fuel costs continued to weigh on operating expenses.”
Felix Lin, President and Chief Executive Officer of HF Foods
“We are actively managing through this pressure by taking actions to mitigate the impact, and the efficiency programs built through our transformation continue to help offset higher costs.”
Felix Lin, President and Chief Executive Officer of HF Foods
Immuneering Corporation appointed Grant C. Bogle, MBA, to its Board of Directors as a Class III Director, effective November 9, 2026. Mr. Bogle will receive compensation under the company's standard non-employee director arrangements and has entered into a standard indemnification agreement.
Appian CEO and President Matthew W. Calkins Sells $1.56M of Stock
Matthew W. Calkins, CEO and President, sold 30,000 shares of Appian Corp at $51.55 to $53.29 a share (average $51.98) in 3 transactions, worth $1.56M in total on Nov 6, 2026. Shares held after the trade: 1,554,144 (-0.1%).
Definium Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing psychedelic-based treatments like DT120 (LSD) and DT402 (MDMA) for psychiatric disorders. As of November 2, 2026, the company had 136,899,935 common shares outstanding and is currently conducting Phase 3 clinical programs for generalized anxiety disorder and major depressive disorder.
Launch One Acquisition Nasdaq/NYSE Compliance Notice
Launch One Acquisition Corp. received a deficiency notice from Nasdaq for failing to meet audit committee composition and board independence requirements following the resignation of director Dr. Rodney A. Ferguson. The company has been granted a cure period until its next annual meeting or one year from the vacancy to appoint a new independent director and regain compliance.
Clearway Energy reported total operating revenues of $1,357 million for the first nine months of 2026, up from $1,119 million in 2025. While net income for the nine-month period improved to $85 million compared to a loss in the prior year, net income attributable to Clearway Energy, Inc. decreased significantly to $10 million due to higher allocations to noncontrolling interests.
ImageneBio, Inc. (formerly Ikena Oncology) is a clinical-stage biopharmaceutical company focused on developing olevaprubart for immunological and inflammatory indications following its 2025 merger with Legacy Inmagene. As of October 31, 2026, the company had 12,456,281 shares of common stock outstanding and expects to incur significant losses for the foreseeable future while requiring substantial additional funding.
AMCON Distributing Company reported its fiscal year 2026 results, achieving net income of $2.4 million and revenues of $3.1 billion. The company highlighted its position as the third largest convenience distributor in the U.S. and its continued focus on strategic acquisition opportunities and technology investments.
Term
FY2026
“AMCON’s long-term strategy of providing superior customer service, custom designed merchandising platforms supported by advertising and leading-edge technology solutions combined with the third largest Convenience Distribution footprint in the United States positions our organization well in the years ahead.”
Christopher H. Atayan, AMCON’s Chairman and Chief Executive Officer
“This summer our management team navigated a monumental logistics challenge presented by wildfires that engulfed a large portion of our service territory in Colorado. Through the hard work and dedication of our associates, we were able to maintain service levels and timely deliveries for our customers across this region.”
Andrew C. Plummer, AMCON’s President and Chief Operating Officer
Occidental Petroleum reported a significant increase in net income for the nine months ended September 30, 2026, reaching $8.18 billion compared to $2.26 billion in the prior year, largely driven by a $3.1 billion gain from discontinued operations related to the OxyChem sale. Total assets decreased to $79.8 billion following the divestiture, while long-term debt was substantially reduced from $20.6 billion to $11.6 billion.
Valor Energy Signs $3.6M M&A Deal with Glorious Star, LLC
Valor Energy Inc. entered into an amendment regarding its acquisition of the Youngstown Computing Center from Glorious Star, LLC for a total purchase price of $3.6 million. The amendment eliminates an escrow arrangement for the $360,000 down payment, allowing direct payment to the seller upon satisfactory due diligence, and clarifies that the acquisition of additional power capacity would be treated as a separate transaction. The closing is expected within thirty business days of the original October 18, 2026 effective date.
Verde Clean Fuels reported a Q3 2026 net loss of $2.0 million, an improvement from the $2.3 million loss in the prior year period. The company maintained a strong balance sheet with $52.6 million in cash and no debt while continuing to evaluate strategic alternatives for its STG+ technology.
Term
Q3 2026
“We are continuing to evaluate strategic alternatives and opportunities to deploy our STG+® technology with a disciplined approach to capital allocation. We remain focused on preserving shareholder capital and evaluating opportunities to maximize shareholder value.”
AlTi Global, Inc. has furnished an updated investor presentation deck regarding its third quarter 2026 earnings. The presentation highlights that the firm currently manages or advises on approximately $95 billion in combined assets with a global network of 450 professionals.
Orchestra BioMed closed an underwritten public offering of 17,250,000 shares of common stock, which included the full exercise of the underwriters' over-allotment option. The offering was priced at $5.00 per share, generating gross proceeds of approximately $86.3 million. The company intends to use the funds to support its AVIM Therapy and Virtue SAB clinical programs, including the BACKBEAT global pivotal trial.
Alta Equipment Group reported third quarter 2026 results with total revenues of $417.4 million, a slight decrease from the prior year. Despite lower revenues, Adjusted EBITDA grew 8% to $44.9 million as the company focused on capital efficiency, reducing inventory and rental fleet carrying values by $45 million since year-end. Material Handling bookings surged 67% year-over-year, signaling a recovery in customer demand and replacement cycles.
Term
Q3 2026
“Our third quarter results reflect the progress we are making to generate stronger earnings and returns from a more efficient capital base. Adjusted EBITDA increased approximately 8% year over year to $44.9 million despite a meaningfully smaller investment in rental fleet and inventory.”
Ryan Greenawalt, Chief Executive Officer
“Within Material Handling, the improvement in demand that we began to see earlier this year continued during the third quarter, with bookings increasing 67% year over year and backlog continuing to grow. We believe this strength reflects improving industry conditions and customers beginning to address pent-up replacement needs following an extended period of fleet replacement deferrals.”
Darren W. Woodell resigned as Vice President and Controller (Principal Accounting Officer) effective November 6, 2026. Jerome T. Upton, the current CFO, was appointed to serve as the interim Principal Accounting Officer until a permanent successor is named. Mr. Upton is also scheduled to become the company's President and CEO on January 1, 2027.
Pathward Financial's Compensation Committee approved a one-time cash payment of $340,923 to former President Anthony Sharett. The payment represents his annual incentive award for fiscal year 2026, which he was otherwise ineligible to receive following his resignation on October 23, 2026. The award was based on the company's achievement of performance measures and Mr. Sharett's service throughout the full fiscal year.
National Health Investors (NHI) furnished a formal investor presentation titled 'Q3 2026 Business Update' on November 9, 2026. The presentation provides a strategic and operational update on the company's senior housing and medical facility real estate portfolio. The filing was made under Item 7.01 to provide transparency to investors regarding current business trends.
Bentley Systems Insider Raymond B. Bentley Sells $23.2M of Stock
Raymond B. Bentley sold 500,000 shares of Bentley Systems Inc at $45.42 to $47.25 a share (average $46.47) in 3 transactions, worth $23.2M in total on Nov 5, 2026. Shares held after the trade: 13,816,404 (-1.3%).